 Influenza pathogens are inserted into the common herpes virus, which infects most people with mild or no symptoms. It creates an immune response against the flu. The vaccine platform is designed to stimulate the body's own immune response, and the one-and-done shot could be available in 5 to 10 years. I'm Lisa Carton.